Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control

Affiliations

¹ Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India.
² Department of Medicine, Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York.

Anoop Misra et al. J Diabetes. 2020 Jul.

. 2020 Jul;12(7):556-557.

doi: 10.1111/1753-0407.13048.

¹ Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India.
² Department of Medicine, Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

References

1. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID‐19 infection are at higher risk of ICU admission and poor short‐term outcome. J Clin Virol. 2020;127:104354. - PMC - PubMed
1. Singh AK, Gupta R, Misra A. Comorbidities in COVID‐19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr. 2020;14:283‐287. - PMC - PubMed
1. Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. Arterial hypertension and risk of death in patients with COVID‐19 infection: systematic review and meta‐analysis. J Infect. 2020. - PMC - PubMed
1. Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020. - PMC - PubMed
1. Pareek M, Bangash MN, Pareek N, et al. Ethnicity and COVID‐19: an urgent public health research priority. Lancet. 2020;395:1421‐1422. - PMC - PubMed